Given that NF-κB signaling is often altered and aberrantly active in numerous malignancies including GBM, and its critical role in supporting tumor progression40 as well as cancer stem cell maintenance41, it is somewhat surprising and unlikely that NF-κB activation would lead to decreased GSCs maintenance. The gene discussed is NFKB1; the disease is cancer.